CAS 25416-65-3
:L-Tyrosin, O-(4-hydroxy-3,5-diiodphenyl)-3,5-diiodo-, Natriumsalz, Hydrat (1:1:?)
- 3,5,3',5'-Tetraiodothyronine
- 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-alanine
- <span class="text-smallcaps">L</span>-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate
- <span class="text-smallcaps">L</span>-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt, hydrate (1:1:?)
- Beta-[(3,5-Diiodo-4-Hydroxyphenoxy)-3,5-Diiodophenyl]Alanine
- L-3,5,3',5'-Tetraiodothyronine
- L-T4
- Levothyroxine
- O-(4-Hydroxy-3,5-Diiodophenyl)-3,5-Diiodo-L-Tyrosin
- O-(4-Hydroxy-3,5-Diiodophenyl)-3,5-Diiodotyrosine
- O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine
- T4(Hormone)
- Tetraiodothyronine
- L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt, hydrate (1:1:?)
- Weitere Synonyme anzeigen
LEVOTHYROXINE SODIUM CRS
CAS:LEVOTHYROXINE SODIUM CRSFormel:C15H11I4NO4Farbe und Form:Added ModifiedMolekulargewicht:776.87LEVOTHYROXINE FOR PEAK IDENTIFICATION CRS
CAS:LEVOTHYROXINE FOR PEAK IDENTIFICATION CRSFormel:C15H11I4NO4Farbe und Form:White. Light Brown. Powder.Molekulargewicht:776.87Levothyroxine Sodium
CAS:Amino-acid derivativesFormel:C15H10I4NO4Na·xH2OFarbe und Form:Off-White Light Yellow PowderMolekulargewicht:798.66864Sodium levothyroxine
CAS:Formel:C15H13I4NNaO5Reinheit:95%Farbe und Form:LiquidMolekulargewicht:817.8751Sodium Levothyroxine Hydrate
CAS:Sodium Levothyroxine HydrateReinheit:98%Molekulargewicht:798.65g/molL-Thyroxine sodium xhydrate
CAS:L-Thyroxine sodium xhydrate is a synthetic thyroid hormone used in the treatment of hypothyroidism.Formel:C15H12I4NNaO5Reinheit:98.96%Farbe und Form:SolidMolekulargewicht:03,3',5,5'-Tetraiodo-L-thyronine sodium hydrate
CAS:3,3',5,5'-Tetraiodo-L-thyronine sodium hydrate is a synthetic thyroid hormone that is used to treat hypothyroidism and myxedema coma. It is also used as an ingredient in pharmaceuticals. 3,3',5,5'-Tetraiodo-L-thyronine sodium hydrate has been shown to be effective in the treatment of hypothyroidism and myxedema coma. The drug exhibits a high degree of bioequivalence with levothyroxine sodium tablets.
MRP2/ABCG2 transport proteins are expressed at high levels in the liver and gut epithelium and play a role in the absorption of 3,3',5,5'-tetraiodo-L-thyronine sodium hydrate from the small intestine into blood circulation. This drug binds to sorbitol and d-mannitol through hydrogen bonding interactions. These interactions may be responsible forFormel:C15H10I4NNaO4•(H2O)xReinheit:Min. 97 Area-%Farbe und Form:PowderMolekulargewicht:798.85









